Completed OBSERVATIONAL NCT04386395

Immune Changes in Severe COVID-19 Pulmonary Infections (COVIDIMM)

Whole Blood Immune Cells Characterization in Critically Ill COVID-19 Patients: A Prospective Study

Sponsor: Central Hospital, Nancy, France

Conditions Immune System Disorder SARS-CoV-2

Updated 6 times since 2020 Last updated: Jul 9, 2021 Started: Mar 30, 2020 Primary completion: May 30, 2020 Completion: Jun 30, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04386395, this observational or N/A phase trial focuses on Immune System Disorder and SARS-CoV-2 and remains completed. Sponsored by Central Hospital, Nancy, France, it has been updated 6 times since 2020, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Completed
Sep 2024 — Sep 2025 [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Sep 2021 — Jul 2024 [monthly]

Completed

Status: Active Not Recruiting → Completed
Jan 2021 — Sep 2021 [monthly]

Active Not Recruiting

▶ Show 1 earlier version

Jun 2020 — Jan 2021 [monthly]

Active Not Recruiting

First recorded

Mar 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Central Hospital, Nancy, France

Data source: Central Hospital, Nancy, France

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Vandœuvre-lès-Nancy, France